Skip to main content
. 2014 Apr 16;28(6):935–948. doi: 10.1210/me.2013-1339

Figure 8.

Figure 8.

A diagram of the proposed androgen-dependent cell proliferation mediated by SGK3 in AR-positive prostate cancer. SGK3 is induced by androgen/AR through a transcriptional mechanism and is activated by phosphoinositide-dependent kinase-1 (PDK1) downstream of PI3K. Activated SGK3 promotes prostate cancer cell proliferation through up-regulation of mTORC1/p70S6K signaling and a subsequent increase in cyclin D1 levels.